Pharma and Biotech

A research-stage biotech built its digital core early — and it carried the company through growth no one had planned for.

Our research with finance and operations leaders reveals the six ERP obstacles most likely to slow emerging biopharma companies — and how top performers get ahead of them.

Emerging biopharma companies have the science. What often holds them back is an operating model built for the lab, not for launch.

Strong back-office operations and financial control are essential during clinical trials. Neglecting them invites compliance risk, delays and wasted capital.

A growing specialty pharma company consolidated three systems onto one cloud ERP in under six months — and closed its first quarter on the new platform on schedule.